Role of ACSL4 in modulating farnesoid X receptor expression and M2 macrophage polarization in HBV-induced hepatocellular carcinoma

Abstract

The intricate relationship between bile acid (BA) metabolism, M2 macrophage polarization, and hepatitis B virus-hepatocellular carcinoma (HBV-HCC) necessitates a thorough investigation of ACSL4’s (acyl-CoA synthetase long-chain family member 4) role. This study combines advanced bioinformatics and experimental methods to elucidate ACSL4’s significance in HBV-HCC development. Using bioinformatics, we identified differentially expressed genes in HBV-HCC. STRING and gene set enrichment analysis analyses were employed to pinpoint critical genes and pathways. Immunoinfiltration analysis, along with in vitro and in vivo experiments, assessed M2 macrophage polarization and related factors. ACSL4 emerged as a pivotal gene influencing HBV-HCC. In HBV-HCC liver tissues, ACSL4 exhibited upregulation, along with increased levels of M2 macrophage markers and BA. Silencing ACSL4 led to heightened farnesoid X receptor (FXR) expression, reduced BA levels, and hindered M2 macrophage polarization, thereby improving HBV-HCC conditions. This study underscores ACSL4’s significant role in HBV-HCC progression. ACSL4 modulates BA-mediated M2 macrophage polarization and FXR expression, shedding light on potential therapeutic targets and novel insights into HBV-HCC pathogenesis.

Keywords

ACSL4 / bile acid metabolism / farnesoid X receptor / hepatitis B virus-hepatocellular carcinoma / M2 macrophage polarization

References

[1] GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022; 7(9): 796-829.

[2] Jiang Y, Han Q, Zhao H, Zhang J. The mechanisms of HBV-induced hepatocellular carcinoma. J Hepatocell Carcinoma. 2021; 8: 435-450.

[3] Tan AT, Schreiber S. Adoptive T-cell therapy for HBV-associated HCC and HBV infection. Antiviral Res. 2020; 176: 104748.

[4] Rizzo GEM, Cabibbo G, Craxì A. Hepatitis B virus-associated hepatocellular carcinoma. Viruses. 2022; 14(5): 986. Published 2022 May 7.

[5] Alvarez M, Benhammou JN, Darci-Maher N, et al. Human liver single nucleus and single cell RNA sequencing identify a hepatocellular carcinoma-associated cell-type affecting survival. Genome Med. 2022; 14(1): 50.

[6] Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022; 400(10360): 1345-1362.

[7] Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018; 391(10127): 1301-1314.

[8] Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv Cancer Res. 2021; 149: 1-61.

[9] Zhang J, Hu C, Xie X, Qi L, Li C, Li S. Immune checkpoint inhibitors in HBV-caused hepatocellular carcinoma therapy. Vaccines (Basel). 2023; 11(3): 614. Published 2023 Mar 8.

[10] Zhang Q, Bi J, Zheng X, et al. Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. Nat Immunol. 2018; 19(7): 723-732.

[11] Xi S, Zheng X, Li X, et al. Activated hepatic stellate cells induce infiltration and formation of CD163⁺ macrophages via CCL2/CCR2 pathway. Front Med (Lausanne). 2021; 8: 627927. Published 2021 Feb 5.

[12] Kong Y, Guo L. Sunitinib suppresses M2 polarization of macrophages in tumor microenvironment to regulate hepatocellular carcinoma progression. J Biochem Mol Toxicol. 2023; 37(6): e23333.

[13] Jiang Y, Han Q, Zhao H, Zhang J. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis. J Exp Clin Cancer Res. 2021; 40(1): 13. Published 2021 Jan 6.

[14] Boutilier AJ, Elsawa SF. Macrophage polarization states in the tumor microenvironment. Int J Mol Sci. 2021; 22(13): 6995. Published 2021 Jun 29.

[15] Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002; 23(11): 549-555.

[16] Shu Y, Qin M, Song Y, et al. M2 polarization of tumor-associated macrophages is dependent on integrin β3 via peroxisome proliferator-activated receptor-γ up-regulation in breast cancer. Immunology. 2020; 160(4): 345-356.

[17] Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1/M2 polarization. Eur J Pharmacol. 2020; 877: 173090.

[18] Fuchs CD, Trauner M. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. Nat Rev Gastroenterol Hepatol. 2022; 19(7): 432-450.

[19] Qian H, Chao X, Williams J, et al. Autophagy in liver diseases: a review. Mol Aspects Med. 2021; 82: 100973.

[20] Režen T, Rozman D, Kovács T, et al. The role of bile acids in carcinogenesis. Cell Mol Life Sci. 2022; 79(5): 243. Published 2022 Apr 16.

[21] Chiang JYL, Ferrell JM. Bile acids as metabolic regulators and nutrient sensors. Annu Rev Nutr. 2019; 39: 175-200.

[22] Sun R, Zhang Z, Bao R, et al. Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis. J Hepatol. 2022; 77(2): 453-466.

[23] Li H, Song J, He Y, et al. CRISPR/Cas9 screens reveal that hexokinase 2 enhances cancer stemness and tumorigenicity by activating the ACSL4-fatty acid β-oxidation pathway. Adv Sci (Weinh). 2022; 9(21): e2105126.

[24] Chen F, Kang R, Liu J, Tang D. The ACSL4 network regulates cell death and autophagy in diseases. Biology (Basel). 2023; 12(6): 864. Published 2023 Jun 15.

[25] Xue Q, Kang R, Klionsky DJ, Tang D, Liu J, Chen X. Copper metabolism in cell death and autophagy. Autophagy. 2023; 19(8): 2175-2195.

[26] Kuwata H, Hara S. Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism. Prostaglandins Other Lipid Mediat. 2019; 144: 106363.

[27] Yang Y, Zhu T, Wang X, et al. ACSL3 and ACSL4, distinct roles in ferroptosis and cancers. Cancers (Basel). 2022; 14(23): 5896. Published 2022 Nov 29.

[28] Li J, Song J, Yan B, et al. Neurotensin differentially regulates bile acid metabolism and intestinal FXR-bile acid transporter axis in response to nutrient abundance. FASEB J. 2021; 35(5): e21371.

[29] Ding L, Yang L, Wang Z, Huang W. Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharm Sin B. 2015; 5(2): 135-144.

[30] Chiang JYL, Ferrell JM. Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. Am J Physiol Gastrointest Liver Physiol. 2020; 318(3): G554-G573.

[31] Katafuchi T, Makishima M. Molecular basis of bile acid-FXR-FGF15/19 signaling axis. Int J Mol Sci. 2022; 23(11): 6046. Published 2022 May 27.

[32] Deng R, Liu S, Shen S, Guo H, Sun J. Circulating HBV RNA: from biology to clinical applications. Hepatology. 2022; 76(5): 1520-1530.

[33] Kim GW, Imam H, Khan M, et al. HBV-induced increased N6 methyladenosine modification of PTEN RNA affects innate immunity and contributes to HCC. Hepatology. 2021; 73(2): 533-547.

[34] Chen J, Ding C, Chen Y, et al. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway. Cancer Lett. 2021; 502: 154-165.

[35] Wang J, Wang Z, Yuan J, Wang J, Shen X. The positive feedback between ACSL4 expression and O-GlcNAcylation contributes to the growth and survival of hepatocellular carcinoma. Aging (Albany NY). 2020; 12(9): 7786-7800.

[36] Tang B, Hu L, Jiang T, et al. A metabolism-related gene prognostic index for prediction of response to immunotherapy in lung adenocarcinoma. Int J Mol Sci. 2022; 23(20): 12143.

[37] Jiang H, Ren Y, Yu J, Hu S, Zhang J. Analysis of lactate metabolism-related genes and their association with immune infiltration in septic shock via bioinformatics method. Front Genet. 2023; 14: 1223243.

[38] Xu Y, Chen W, Liang J, et al. The miR-1185-2-3p-GOLPH3L pathway promotes glucose metabolism in breast cancer by stabilizing p53-induced SERPINE1. J Exp Clin Cancer Res. 2021; 40(1): 47.

[39] Bai L, Wang W, Xiang Y, Wang S, Wan S, Zhu Y. Aberrant elevation of GDF8 impairs granulosa cell glucose metabolism via upregulating SERPINE1 expression in patients with PCOS. Mol Ther Nucleic Acids. 2020; 23: 294-309.

[40] Tu B, Fang R, Zhu Z, Chen G, Peng C, Ning R. Comprehensive analysis of arachidonic acid metabolism-related genes in diagnosis and synovial immune in osteoarthritis: based on bulk and single-cell RNA sequencing data. Inflamm Res. 2023; 72(5): 955-970.

[41] Wang H, Guo H, Sun J, Wang Y. Multi-omics analyses based on genes associated with oxidative stress and phospholipid metabolism revealed the intrinsic molecular characteristics of pancreatic cancer. Sci Rep. 2023; 13(1): 13564. Published 2023 Aug 21.

[42] Luo J, An J, Jia R, Liu C, Zhang Y. Identification and verification of metabolism-related immunotherapy features and prognosis in lung adenocarcinoma. Curr Med Chem. Published online March 15, 2024.

[43] Yang T, Luo Y, Liu J, et al. A novel signature incorporating lipid metabolism-and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma. Front Oncol. 2023; 13: 1182434. Published 2023 Jun 6.

[44] Häder T, Müller S, Aguilera M, et al. Control of triglyceride storage by a WD40/TPR-domain protein. EMBO Rep. 2003; 4(5): 511-516.

[45] Yan H, Li Z, Shen Q, et al. Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence. Pathol Res Pract. 2017; 213(4): 316-321.

[46] Platten M, Nollen EAA, Röhrig UF, Fallarino F, Opitz CA. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019; 18(5): 379-401.

[47] Ahonen MA, Höring M, Nguyen VD, et al. Insulin-inducible THRSP maintains mitochondrial function and regulates sphingolipid metabolism in human adipocytes. Mol Med. 2022; 28(1): 68. Published 2022 Jun 17.

[48] Peng H, Chen B, Wei W, et al. N⁶-methyladenosine (m⁶A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation. Nat Metab. 2022; 4(8): 1041-1054.

[49] Wu Y, Hao X, Wei H, Sun R, Chen Y, Tian Z. Blockade of T-cell receptor with Ig and ITIM domains elicits potent antitumor immunity in naturally occurring HBV-related HCC in mice. Hepatology. 2023; 77(3): 965-981.

[50] Hao X, Chen Y, Bai L, Wei H, Sun R, Tian Z. HBsAg-specific CD8⁺ T cells as an indispensable trigger to induce murine hepatocellular carcinoma. Cell Mol Immunol. 2021; 18(1): 128-137.

[51] Liao P, Wang W, Wang W, et al. CD8⁺ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022; 40(4): 365-378. e6.

[52] Liang YJ, Teng W, Chen CL, et al. Clinical implications of HBV PreS/S mutations and the effects of PreS2 deletion on mitochondria, liver fibrosis, and cancer development. Hepatology. 2021; 74(2): 641-655.

[53] Lu Y, Sun Q, Guan Q, et al. The XOR-IDH3α axis controls macrophage polarization in hepatocellular carcinoma. J Hepatol. 2023; 79(5): 1172-1184.

[54] Hu YX, Liu Z, Zhang Z, et al. Antihepatoma peptide, scolopentide, derived from the centipede scolopendra subspinipes mutilans. World J Gastroenterol. 2023; 29(12): 1875-1898.

[55] Kang MJ, Fujino T, Sasano H, et al. A novel arachidonate-preferring acyl-CoA synthetase is present in steroidogenic cells of the rat adrenal, ovary, and testis. Proc Natl Acad Sci USA. 1997; 94(7): 2880-2884.

[56] Killion EA, Reeves AR, El Azzouny MA, et al. A role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunction. Mol Metab. 2018; 9: 43-56.

[57] Dixon SJ, Winter GE, Musavi LS, et al. Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem Biol. 2015; 10(7): 1604-1609.

[58] Tan AT, Bertoletti A. HBV-HCC treatment with mRNA electroporated HBV-TCR T cells. Immunother Adv. 2021; 2(1): ltab026. Published 2021 Dec 24.

[59] Li CY, Cai JH, Tsai JJP, Wang CCN. Identification of hub genes associated with development of head and neck squamous cell carcinoma by integrated bioinformatics analysis. Front Oncol. 2020; 10: 681. Published 2020 May 22.

[60] Jia L, Cheng M. Correlation analysis between risk factors, BMD and serum osteocalcin, CatheK, PINP, β-crosslaps, TRAP, lipid metabolism and BMI in 128 patients with postmenopausal osteoporotic fractures. Eur Rev Med Pharmacol Sci. 2022; 26(21): 7955-7959.

[61] Conde de la Rosa L, Garcia-Ruiz C, Vallejo C, et al. STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway. J Hepatol. 2021; 74(6): 1429-1441.

[62] Dong J, Zhang R, Xia Y, et al. The necroptosis related gene LGALS3 can be used as a biomarker for the adverse progression from chronic HBV infection to HCC. Front Immunol. 2023; 14: 1142319. Published 2023 Apr 26.

[63] Li B, Li Y, Li S, Li H, Liu L, Yu H. Circ_MTM1 knockdown inhibits the progression of HBV-related liver fibrosis via regulating IL7R expression through targeting miR-122-5p. Am J Transl Res. 2022; 14(4): 2199-2211.

[64] Chen J, Chen T, Zhu Y, et al. circPTN sponges miR-145-5p/miR-330-5p to promote proliferation and stemness in glioma. J Exp Clin Cancer Res. 2019; 38(1): 398. Published 2019 Sep 11.

[65] Liu Q, Yang C, Wang S, et al. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression. Cell Commun Signal. 2020; 18(1): 51. Published 2020 Mar 30.

[66] Fujiwara T, Yakoub MA, Chandler A, et al. CSF1/CSF1R signaling inhibitor pexidartinib (PLX3397) reprograms tumor-associated macrophages and stimulates T-cell infiltration in the sarcoma microenvironment. Mol Cancer Ther. 2021; 20(8): 1388-1399.

[67] Xie C, Wang S, Zhang H, et al. Lnc-AIFM2-1 promotes HBV immune escape by acting as a ceRNA for miR-330-3p to regulate CD244 expression. Front Immunol. 2023; 14: 1121795. Published 2023 Feb 9.

[68] Wu J, Zhang T, Chen Y, Ha S. MiR-139-5p influences hepatocellular carcinoma cell invasion and proliferation capacities via decreasing SLITRK4 expression. Biosci Rep. 2020; 40(5): BSR20193295.

[69] Wang J, Zhao W, Cheng L, et al. CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice. J Immunol. 2010; 185(12): 7654-7662.

[70] Ma C, Kesarwala AH, Eggert T, et al. NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature. 2016; 531(7593): 253-257.

[71] Liu G, Yin L, Ouyang X, Zeng K, Xiao Y, Li Y. M2 macrophages promote HCC cells invasion and migration via miR-149-5p/MMP9 signaling. J Cancer. 2020; 11(5): 1277-1287. Published 2020 Jan 1.

[72] Jia Y, Liu X, Xu L, Ni J, Sun L, Li C. Rapid determination of 20 bile acids in human serum by ultra performance liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 2021; 35(5): e5063.

[73] Xie G, Jiang R, Wang X, et al. Conjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesis. EBioMedicine. 2021; 66: 103290.

[74] Chen D, Zeng R, Teng G, et al. Menstrual blood-derived mesenchymal stem cells attenuate inflammation and improve the mortality of acute liver failure combining with A2AR agonist in mice. J Gastroenterol Hepatol. 2021; 36(9): 2619-2627.

[75] Ludwig T, Worsch S, Heikenwalder M, Daniel H, Hauner H, Bader BL. Metabolic and immunomodulatory effects of n-3 fatty acids are different in mesenteric and epididymal adipose tissue of diet-induced obese mice. Am J Physiol Endocrinol Metab. 2013; 304(11): E1140-E1156.

[76] Yarilin D, Xu K, Turkekul M, et al. Machine-based method for multiplex in situ molecular characterization of tissues by immunofluorescence detection. Sci Rep. 2015; 5: 9534.

RIGHTS & PERMISSIONS

2024 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.